Literature DB >> 24990196

Researchers' perspectives on the role of study partners in dementia research.

Betty S Black1, Holly Taylor2, Peter V Rabins1, Jason Karlawish3.   

Abstract

BACKGROUND: Study partners for dementia research participants are vital to the research process, but little is known about their role, responsibilities, and experiences. Study partners are usually family members or friends - often the patient's informal caregiver - who are knowledgeable about and usually accompany the participant to study visits. This study examines researchers' perspectives on the role of study partners in dementia research.
METHODS: Qualitative data collection and analytic methods were used. Semi-structured individual interviews with principal investigators, study coordinators, and research nurses (i.e. researchers; n = 17) at two academic research sites were recorded, transcribed, and content analyzed to identify themes in the data.
RESULTS: According to researchers, study partners either make or help make research enrollment and post-enrollment decisions, serve as knowledgeable informants for the participants, manage the logistics that enable participants to comply with a study's protocol, and provide comfort and encouragement for the patient to engage in and complete a study. Researchers describe ideal qualities of study partners as being able to provide reliable information, being dependable and adherent to the protocol, and not expecting a benefit. They also report that study partners may face both practical and emotional challenges during research participation. However, researchers believe that study partners derive dementia-related education, caregiver support, and satisfaction from their involvement in research.
CONCLUSIONS: Investigators, potential study partners, and institutional review boards should be aware of study partners' research responsibilities, challenges, and their interests as caregivers.

Entities:  

Mesh:

Year:  2014        PMID: 24990196      PMCID: PMC4349344          DOI: 10.1017/S1041610214001203

Source DB:  PubMed          Journal:  Int Psychogeriatr        ISSN: 1041-6102            Impact factor:   3.878


  15 in total

1.  How do AD patients and their caregivers decide whether to enroll in a clinical trial?

Authors:  J H Karlawish; D Casarett; J Klocinski; P Sankar
Journal:  Neurology       Date:  2001-03-27       Impact factor: 9.910

2.  Caregivers as subjects of clinical drug trials: a review of human subjects protection practices in published studies of Alzheimer's disease pharmacotherapies.

Authors:  Jennifer Hagerty Lingler; Lisa S Parker; Steven T DeKosky; Richard Schulz
Journal:  IRB       Date:  2006 May-Jun

3.  How redesigning AD clinical trials might increase study partners' willingness to participate.

Authors:  Jason Karlawish; Mark S Cary; Jonathan Rubright; Tom Tenhave
Journal:  Neurology       Date:  2008-12-02       Impact factor: 9.910

Review 4.  A systematic review and meta-analysis of ethnic differences in use of dementia treatment, care, and research.

Authors:  Claudia Cooper; Alec Robert Tandy; Thana B S Balamurali; Gill Livingston
Journal:  Am J Geriatr Psychiatry       Date:  2010-03       Impact factor: 4.105

5.  Assessment of community functioning in people with schizophrenia and other severe mental illnesses: a white paper based on an NIMH-sponsored workshop.

Authors:  Alan S Bellack; Michael F Green; Judith A Cook; Wayne Fenton; Philip D Harvey; Robert K Heaton; Thomas Laughren; Andrew C Leon; Donna J Mayo; Donald L Patrick; Thomas L Patterson; Andrew Rose; Ellen Stover; Til Wykes
Journal:  Schizophr Bull       Date:  2006-08-24       Impact factor: 9.306

6.  ADCS Prevention Instrument Project: ADCS-clinicians' global impression of change scales (ADCS-CGIC), self-rated and study partner-rated versions.

Authors:  Lon S Schneider; Christopher M Clark; Rachelle Doody; Steven H Ferris; John C Morris; Rema Raman; Barry Reisberg; Frederick A Schmitt
Journal:  Alzheimer Dis Assoc Disord       Date:  2006 Oct-Dec       Impact factor: 2.703

7.  Are patients whose study partners are spouses more likely to be eligible for Alzheimer's disease clinical trials?

Authors:  Joshua D Grill; Sarah Monsell; Jason Karlawish
Journal:  Dement Geriatr Cogn Disord       Date:  2012-07-02       Impact factor: 2.959

8.  Correlates of psychological distress in study partners of older people with and without mild cognitive impairment (MCI) - the Sydney Memory and Ageing Study.

Authors:  Katrin M Seeher; Lee-Fay Low; Simone Reppermund; Melissa J Slavin; Brian M Draper; Kristan Kang; Nicole A Kochan; Julian N Trollor; Perminder S Sachdev; Henry Brodaty
Journal:  Aging Ment Health       Date:  2014-03-03       Impact factor: 3.658

9.  Effect of study partner on the conduct of Alzheimer disease clinical trials.

Authors:  Joshua D Grill; Rema Raman; Karin Ernstrom; Paul Aisen; Jason Karlawish
Journal:  Neurology       Date:  2012-12-19       Impact factor: 9.910

Review 10.  Caregiver burden among dementia patient caregivers: a review of the literature.

Authors:  Lynn Etters; Debbie Goodall; Barbara E Harrison
Journal:  J Am Acad Nurse Pract       Date:  2008-08
View more
  7 in total

1.  Study partners perform essential tasks in dementia research and can experience burdens and benefits in this role.

Authors:  Betty S Black; Holly A Taylor; Peter V Rabins; Jason Karlawish
Journal:  Dementia (London)       Date:  2016-05-13

2.  You've Got a Friend in Me: How Cognitively Unimpaired Older Adults Select a Study Partner to Participate with Them in Alzheimer's Disease Research.

Authors:  Emily A Largent; Twisha Bhardwaj; Justin T Clapp; Olivia Saúl Sykes; Kristin Harkins; Joshua D Grill
Journal:  J Alzheimers Dis       Date:  2022-03-18       Impact factor: 4.160

3.  Dyadic Enrollment in a Phase 3 Mild Cognitive Impairment Clinical Trial.

Authors:  Navneet R Hakhu; Daniel L Gillen; Joshua D Grill
Journal:  Alzheimer Dis Assoc Disord       Date:  2022-04-29       Impact factor: 2.357

4.  Study partners: essential collaborators in discovering treatments for Alzheimer's disease.

Authors:  Emily A Largent; Jason Karlawish; Joshua D Grill
Journal:  Alzheimers Res Ther       Date:  2018-09-27       Impact factor: 6.982

5.  Recruiting hard to reach populations to studies: breaking the silence: an example from a study that recruited people with dementia.

Authors:  Becky Field; Gail Mountain; Jane Burgess; Laura Di Bona; Daniel Kelleher; Jacqueline Mundy; Jennifer Wenborn
Journal:  BMJ Open       Date:  2019-11-19       Impact factor: 2.692

6.  Experiences of Participation in a Multimodal Preventive Trial MIND-ADMINI Among Persons with Prodromal Alzheimer's Disease: A Qualitative Study.

Authors:  Ulrika Akenine; Charlotta Thunborg; Miia Kivipelto; Mandana Fallahpour
Journal:  J Multidiscip Healthc       Date:  2022-01-29

7.  Common Data Elements to Facilitate Sharing and Re-use of Participant-Level Data: Assessment of Psychiatric Comorbidity Across Brain Disorders.

Authors:  Anthony L Vaccarino; Derek Beaton; Sandra E Black; Pierre Blier; Farnak Farzan; Elizabeth Finger; Jane A Foster; Morris Freedman; Benicio N Frey; Susan Gilbert Evans; Keith Ho; Mojib Javadi; Sidney H Kennedy; Raymond W Lam; Anthony E Lang; Bianca Lasalandra; Sara Latour; Mario Masellis; Roumen V Milev; Daniel J Müller; Douglas P Munoz; Sagar V Parikh; Franca Placenza; Susan Rotzinger; Claudio N Soares; Alana Sparks; Stephen C Strother; Richard H Swartz; Brian Tan; Maria Carmela Tartaglia; Valerie H Taylor; Elizabeth Theriault; Gustavo Turecki; Rudolf Uher; Lorne Zinman; Kenneth R Evans
Journal:  Front Psychiatry       Date:  2022-02-07       Impact factor: 4.157

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.